Table of Contents 1 Measles, Mumps and Rubella (MMR) Vaccines Market Overview 1.1 Product Overview and Scope of Measles, Mumps and Rubella (MMR) Vaccines 1.2 Measles, Mumps and Rubella (MMR) Vaccines Segment by Type 1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Monovalent Vaccine 1.2.3 Polyvalent Vaccine 1.3 Measles, Mumps and Rubella (MMR) Vaccines Segment by Application 1.3.1 Measles, Mumps and Rubella (MMR) Vaccines Sales Comparison by Application: 2020 VS 2026 1.3.2 Immune Center 1.3.3 Vaccine Development Agencies and Organizations 1.3.4 Hospital 1.3.5 Laboratory 1.3.6 Biotechnology and Biopharmaceutical Companies 1.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Estimates and Forecasts 1.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue 2015-2026 1.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales 2015-2026 1.4.3 Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region: 2020 Versus 2026 2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Competition by Manufacturers 2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2015-2020) 2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020) 2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Sites, Area Served, Product Type 2.5 Measles, Mumps and Rubella (MMR) Vaccines Market Competitive Situation and Trends 2.5.1 Measles, Mumps and Rubella (MMR) Vaccines Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Measles, Mumps and Rubella (MMR) Vaccines Players (Opinion Leaders) 3 Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario by Region 3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.3.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.4.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.4.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Region 3.5.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region 3.5.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.6.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.6.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Facts & Figures by Country 3.7.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.7.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Type 4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2015-2020) 4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2015-2020) 4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price Market Share by Type (2015-2020) 4.4 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Measles, Mumps and Rubella (MMR) Vaccines Historic Market Analysis by Application 5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020) 5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2015-2020) 5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2015-2020) 6 Company Profiles and Key Figures in Measles, Mumps and Rubella (MMR) Vaccines Business 6.1 Medlmmune 6.1.1 Corporation Information 6.1.2 Medlmmune Description, Business Overview and Total Revenue 6.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Medlmmune Products Offered 6.1.5 Medlmmune Recent Development 6.2 Johnson & Johnson 6.2.1 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.2.2 Johnson & Johnson Description, Business Overview and Total Revenue 6.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Johnson & Johnson Products Offered 6.2.5 Johnson & Johnson Recent Development 6.3 Merck 6.3.1 Merck Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.3.2 Merck Description, Business Overview and Total Revenue 6.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Merck Products Offered 6.3.5 Merck Recent Development 6.4 Sanofi 6.4.1 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.4.2 Sanofi Description, Business Overview and Total Revenue 6.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Sanofi Products Offered 6.4.5 Sanofi Recent Development 6.5 Serum 6.5.1 Serum Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.5.2 Serum Description, Business Overview and Total Revenue 6.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Serum Products Offered 6.5.5 Serum Recent Development 6.6 Bavarian Nordic 6.6.1 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.6.2 Bavarian Nordic Description, Business Overview and Total Revenue 6.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Bavarian Nordic Products Offered 6.6.5 Bavarian Nordic Recent Development 6.7 Astellas Pharma 6.6.1 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.6.2 Astellas Pharma Description, Business Overview and Total Revenue 6.6.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Astellas Pharma Products Offered 6.7.5 Astellas Pharma Recent Development 6.8 Emergent BioSolutions 6.8.1 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.8.2 Emergent BioSolutions Description, Business Overview and Total Revenue 6.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Emergent BioSolutions Products Offered 6.8.5 Emergent BioSolutions Recent Development 6.9 GlaxoSmithKline 6.9.1 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.9.2 GlaxoSmithKline Description, Business Overview and Total Revenue 6.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.9.4 GlaxoSmithKline Products Offered 6.9.5 GlaxoSmithKline Recent Development 6.10 Pfizer 6.10.1 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.10.2 Pfizer Description, Business Overview and Total Revenue 6.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Pfizer Products Offered 6.10.5 Pfizer Recent Development 6.11 CSL 6.11.1 CSL Measles, Mumps and Rubella (MMR) Vaccines Production Sites and Area Served 6.11.2 CSL Measles, Mumps and Rubella (MMR) Vaccines Description, Business Overview and Total Revenue 6.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Revenue and Gross Margin (2015-2020) 6.11.4 CSL Products Offered 6.11.5 CSL Recent Development 7 Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Cost Analysis 7.1 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines 7.4 Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors List 8.3 Measles, Mumps and Rubella (MMR) Vaccines Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Type (2021-2026) 10.2 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Application (2021-2026) 10.3 Measles, Mumps and Rubella (MMR) Vaccines Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Measles, Mumps and Rubella (MMR) Vaccines by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Measles, Mumps and Rubella (MMR) Vaccines by Region (2021-2026) 10.4 North America Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026) 10.5 Europe Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026) 10.6 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026) 10.7 Latin America Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026) 10.8 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Growth Rate Comparison by Type (2015-2026) Table 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Comparison by Application: 2020 VS 2026 Table 3. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type (K Doses) (US$ Million) (2020 VS 2026) Table 4. Global Key Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Covered in This Study Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Manufacturers (2015-2020) Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2015-2020) Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Measles, Mumps and Rubella (MMR) Vaccines Average Price (USD/Dose) of Key Manufacturers (2015-2020) Table 10. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Sales Sites and Area Served Table 11. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Types Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Measles, Mumps and Rubella (MMR) Vaccines Players Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Region (2015-2020) Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020) Table 18. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) by Region (2015-2020) Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020) Table 20. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses) Table 21. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020) Table 22. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million) Table 23. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020) Table 24. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses) Table 25. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020) Table 26. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2015-2020) (K Doses) Table 29. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020) Table 32. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses) Table 33. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020) Table 34. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2015-2020) (K Doses) Table 37. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country (2015-2020) Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Type (2015-2020) Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2015-2020) Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) by Type (2015-2020) Table 43. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2015-2020) Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Price (USD/Dose) by Type (2015-2020) Table 45. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) by Application (2015-2020) Table 46. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020) Table 47. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate by Application (2015-2020) Table 48. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 49. Medlmmune Description and Business Overview Table 50. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 51. Medlmmune Main Product Table 52. Medlmmune Recent Development Table 53. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 54. Johnson & Johnson Corporation Information Table 55. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 56. Johnson & Johnson Main Product Table 57. Johnson & Johnson Recent Development Table 58. Merck Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 59. Merck Corporation Information Table 60. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 61. Merck Main Product Table 62. Merck Recent Development Table 63. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 64. Sanofi Corporation Information Table 65. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 66. Sanofi Main Product Table 67. Sanofi Recent Development Table 68. Serum Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 69. Serum Corporation Information Table 70. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 71. Serum Main Product Table 72. Serum Recent Development Table 73. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 74. Bavarian Nordic Corporation Information Table 75. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 76. Bavarian Nordic Main Product Table 77. Bavarian Nordic Recent Development Table 78. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 79. Astellas Pharma Corporation Information Table 80. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 81. Astellas Pharma Main Product Table 82. Astellas Pharma Recent Development Table 83. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 84. Emergent BioSolutions Corporation Information Table 85. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 86. Emergent BioSolutions Main Product Table 87. Emergent BioSolutions Recent Development Table 88. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 89. GlaxoSmithKline Corporation Information Table 90. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 91. GlaxoSmithKline Main Product Table 92. GlaxoSmithKline Recent Development Table 93. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 94. Pfizer Corporation Information Table 95. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 96. Pfizer Main Product Table 97. Pfizer Recent Development Table 98. CSL Measles, Mumps and Rubella (MMR) Vaccines Corporation Information Table 99. CSL Corporation Information Table 100. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020) Table 101. CSL Main Product Table 102. CSL Recent Development Table 103. Sales Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Measles, Mumps and Rubella (MMR) Vaccines Distributors List Table 106. Measles, Mumps and Rubella (MMR) Vaccines Customers List Table 107. Market Key Trends Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 109. Key Challenges Table 110. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Type (2021-2026) Table 111. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Type (2021-2026) Table 112. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Forecast by Type (2021-2026) Table 113. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 114. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Application (2021-2026) Table 115. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) Forecast by Application (2021-2026) Table 116. Global Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) Forecast by Region (2021-2026) Table 117. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share Forecast by Region (2021-2026) Table 118. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share Forecast by Region (2021-2026) Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Measles, Mumps and Rubella (MMR) Vaccines Figure 2. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type: 2020 VS 2026 Figure 3. Monovalent Vaccine Product Picture Figure 4. Polyvalent Vaccine Product Picture Figure 5. Global Measles, Mumps and Rubella (MMR) Vaccines Consumption Market Share by Application: 2020 VS 2026 Figure 6. Immune Center Figure 7. Vaccine Development Agencies and Organizations Figure 8. Hospital Figure 9. Laboratory Figure 10. Biotechnology and Biopharmaceutical Companies Figure 11. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size 2015-2026 (US$ Million) Figure 12. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Capacity (K Doses) (2015-2026) Figure 13. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers in 2020 Figure 15. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2019 Figure 17. Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2015-2020) Figure 19. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2019 Figure 20. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2015-2020) Figure 21. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2019 Figure 22. North America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019 Figure 23. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019 Figure 24. U.S. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 25. U.S. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 27. Canada Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019 Figure 29. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019 Figure 30. Germany Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 31. Germany Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 33. France Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 35. U.K. Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 37. Italy Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 39. Russia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region in 2019 Figure 41. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region in 2019 Figure 42. China Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 43. China Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 45. Japan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 47. South Korea Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 49. India Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 51. Australia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 53. Taiwan Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 55. Indonesia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 57. Thailand Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 59. Malaysia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 61. Philippines Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 63. Vietnam Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019 Figure 65. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019 Figure 66. Mexico Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 67. Mexico Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 69. Brazil Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 71. Argentina Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Country in 2019 Figure 74. Turkey Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 75. Turkey Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 77. Saudi Arabia Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 79. U.A.E Measles, Mumps and Rubella (MMR) Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2015-2020) Figure 81. Sales Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2019 Figure 82. Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Type (2015-2020) Figure 83. Revenue Market Share of Measles, Mumps and Rubella (MMR) Vaccines by Type in 2019 Figure 84. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Growth by Type (2015-2020) (K Doses) Figure 85. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2015-2020) Figure 86. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Application (2015-2020) Figure 88. Global Revenue Share of Measles, Mumps and Rubella (MMR) Vaccines by Application in 2020 Figure 89. Medlmmune Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Serum Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. CSL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Measles, Mumps and Rubella (MMR) Vaccines Figure 102. Manufacturing Process Analysis of Measles, Mumps and Rubella (MMR) Vaccines Figure 103. Measles, Mumps and Rubella (MMR) Vaccines Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 108. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 110. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Medlmmune Johnson & Johnson Merck Sanofi Serum Bavarian Nordic Astellas Pharma Emergent BioSolutions GlaxoSmithKline Pfizer CSL